重新评估血小板增多症作为游离皮瓣手术危险因素:时机是否重要?
该研究回顾性分析502例游离皮瓣重建患者,比较血小板增多(>400,000)与血小板正常(<400,000)者的皮瓣结局。术后血小板增多组返回手术室率44.4% vs 19.4%(P<0.001),静脉血栓导致返回手术室率18.5% vs 2.2%(P<0.001),但皮瓣成功率88.7% vs 92.11%无统计学显著差异(P=0.71)。结论认为术后血小板增多与静脉血栓风险增加相关,但未导致皮瓣失败增加。
要点
- 术后血小板增多组返回手术室率44.4% vs 血小板正常组19.4%(P<0.001)。
- 术后血小板增多组静脉血栓导致返回手术室率18.5% vs 正常组2.2%(P<0.001)。
- 皮瓣成功率术后血小板增多组88.7% vs 正常组92.11%,无统计学显著差异(P=0.71)。
核心结论
- 术后血小板增多患者静脉血栓风险增加,但未导致皮瓣失败增加;血小板增多可能是整体炎症的标志而非皮瓣失败的前兆。
研究设计与样本
- 本机构对过去6年内所有接受游离皮瓣重建的患者进行回顾性病历审查,共502例患者。
主要发现
- 502例患者中71例血小板计数>400,000(35例术前,36例术后),431例血小板计数<400,000。
- 42例重建失败(皮瓣成功率91.6%),111例返回手术室。
- 术后血小板增多组24例皮瓣返回手术室(44.4%),无血小板增多组87例(19.4%;P<0.001)。
- 术后血小板增多组10例返回手术室因蒂部静脉血栓(18.5%),血小板正常组10例因静脉血栓返回(2.2%;P<0.001)。
- 术后血小板增多组与血小板正常组皮瓣成功率分别为88.7%与92.11%,无统计学显著差异(P=0.71);血小板增多组总体术后并发症发生率更高(P=0.002)。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
INTRODUCTION: Thrombocytosis, defined as a platelet count >400,000, has been implicated as a risk factor in free flap failure. Despite proposed mechanisms of pedicle thrombosis, recent studies have suggested that thrombocytosis has no effect on free tissue transfer viability. Risk factors that may compromise successful free tissue transfer should be understood and elucidated, with particular attention to thrombocytosis and its conflicting evidence in the literature. We hypothesize that thrombocytosis has no bearing on free flap success or the rates of pedicle thrombosis. METHODS: Our institution performed a retrospective chart review on all patients who underwent free flap reconstruction over the past 6 years. Patient demographics, medical history, type and location of free tissue transfer, preoperative platelets, postoperative platelets, and flap outcomes and complications (wound dehiscence, infection, hematoma, seroma, and need for blood transfusion) were recorded. Independent t test, Mann-Whitney U tests, χ2 test, and Fisher exact tests were used to determine P values to compare flap outcomes in patients with thrombocytosis (platelet count >400,000) and those with platelet counts less than 400,000. RESULTS: In our 502-patient cohort, 71 were found to have a platelet count >400,000 (35 preoperatively and 36 postoperatively) and 431 patients had platelet counts <400,000. There were 42 reconstructive failures (flap success rate of 91.6%) and 111 returns to the operating room (OR). For patients with postoperative thrombocytosis, 24 flaps returned to the OR (44.4%), whereas in patients without thrombocytosis, 87 flaps returned to the OR (19.4%; P < 0.001). In patients with postoperative thrombocytosis, 10 OR returns were due to pedicle venous thrombosis (18.5%), in comparison to 10 returns for venous thrombosis in those with normal platelets (2.2%; P < 0.001). There was a small difference in free flap success rates between those with postoperative thrombocytosis and normal platelets, 88.7% versus 92.11%; however, this was not statistically significant ( P = 0.71). The thrombocytosis group had a higher incidence of overall postoperative complications ( P = 0.002). CONCLUSIONS: Thrombocytosis has historically been cited as a risk factor for free flap reconstruction failure with recent conflicting evidence in the literature. In patients with postoperative thrombocytosis, we found an increased risk of venous thrombosis; however, this did not result in increased flap failure. There was an increase in postoperative complications, which corresponds with National Surgical Quality Improvement Program data reported in the literature. We suspect that thrombocytosis is not a harbinger of free flap failure but rather a marker for overall inflammation, which may confer a higher rate of venous thrombosis requiring reoperation and postoperative complications.
引用
- Fisher AH, Jones I, Malta K, et al. Reevaluating Thrombocytosis as a Risk Factor in Free Flap Surgery: Does Timing Matter? Ann Plast Surg. 2023. PMID: 37962259. doi:10.1097/SAP.0000000000003710
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。